202 related articles for article (PubMed ID: 36170795)
1. Genetically defined individual reference ranges for tryptase limit unnecessary procedures and unmask myeloid neoplasms.
Chovanec J; Tunc I; Hughes J; Halstead J; Mateja A; Liu Y; O'Connell MP; Kim J; Park YH; Wang Q; Le Q; Pirooznia M; Trivedi NN; Bai Y; Yin Y; Hsu AP; McElwee J; Lassiter S; Nelson C; Bandoh J; DiMaggio T; Šelb J; Rijavec M; Carter MC; Komarow HD; Sabato V; Steinberg J; Hafer KM; Feuille E; Hourigan CS; Lack J; Khoury P; Maric I; Zanotti R; Bonadonna P; Schwartz LB; Milner JD; Glover SC; Ebo DG; Korošec P; Caughey GH; Brittain EH; Busby B; Metcalfe DD; Lyons JJ
Blood Adv; 2023 May; 7(9):1796-1810. PubMed ID: 36170795
[TBL] [Abstract][Full Text] [Related]
2. Elevated Basal Serum Tryptase: Disease Distribution and Variability in a Regional Health System.
Waters AM; Park HJ; Weskamp AL; Mateja A; Kachur ME; Lyons JJ; Rosen BJ; Boggs NA
J Allergy Clin Immunol Pract; 2022 Sep; 10(9):2424-2435.e5. PubMed ID: 35032694
[TBL] [Abstract][Full Text] [Related]
3. Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis.
Greiner G; Sprinzl B; Górska A; Ratzinger F; Gurbisz M; Witzeneder N; Schmetterer KG; Gisslinger B; Uyanik G; Hadzijusufovic E; Esterbauer H; Gleixner KV; Krauth MT; Pfeilstöcker M; Keil F; Gisslinger H; Nedoszytko B; Niedoszytko M; Sperr WR; Valent P; Hoermann G
Blood; 2021 Jan; 137(2):238-247. PubMed ID: 32777817
[TBL] [Abstract][Full Text] [Related]
4. The Normal Range of Baseline Tryptase Should Be 1 to 15 ng/mL and Covers Healthy Individuals With HαT.
Valent P; Hoermann G; Bonadonna P; Hartmann K; Sperr WR; Broesby-Olsen S; Brockow K; Niedoszytko M; Hermine O; Chantran Y; Butterfield JH; Greiner G; Carter MC; Sabato V; Radia DH; Siebenhaar F; Triggiani M; Gülen T; Alvarez-Twose I; Staudinger T; Traby L; Sotlar K; Reiter A; Horny HP; Orfao A; Galli SJ; Schwartz LB; Lyons JJ; Gotlib J; Metcalfe DD; Arock M; Akin C
J Allergy Clin Immunol Pract; 2023 Oct; 11(10):3010-3020. PubMed ID: 37572755
[TBL] [Abstract][Full Text] [Related]
5. Incorporating Tryptase Genotyping Into the Workup and Diagnosis of Mast Cell Diseases and Reactions.
Lyons JJ; Greiner G; Hoermann G; Metcalfe DD
J Allergy Clin Immunol Pract; 2022 Aug; 10(8):1964-1973. PubMed ID: 35597543
[TBL] [Abstract][Full Text] [Related]
6. The Genetic Basis and Clinical Impact of Hereditary Alpha-Tryptasemia.
Luskin KT; White AA; Lyons JJ
J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2235-2242. PubMed ID: 33744473
[TBL] [Abstract][Full Text] [Related]
7. Heritable risk for severe anaphylaxis associated with increased α-tryptase-encoding germline copy number at TPSAB1.
Lyons JJ; Chovanec J; O'Connell MP; Liu Y; Šelb J; Zanotti R; Bai Y; Kim J; Le QT; DiMaggio T; Schwartz LB; Komarow HD; Rijavec M; Carter MC; Milner JD; Bonadonna P; Metcalfe DD; Korošec P
J Allergy Clin Immunol; 2021 Feb; 147(2):622-632. PubMed ID: 32717252
[TBL] [Abstract][Full Text] [Related]
8. Defining baseline variability of serum tryptase levels improves accuracy in identifying anaphylaxis.
Mateja A; Wang Q; Chovanec J; Kim J; Wilson KJ; Schwartz LB; Glover SC; Carter MC; Metcalfe DD; Brittain E; Lyons JJ
J Allergy Clin Immunol; 2022 Mar; 149(3):1010-1017.e10. PubMed ID: 34425177
[TBL] [Abstract][Full Text] [Related]
9. Disease correlates and clinical relevance of hereditary α-tryptasemia in patients with systemic mastocytosis.
Sordi B; Vanderwert F; Crupi F; Gesullo F; Zanotti R; Bonadonna P; Crosera L; Elena C; Fiorelli N; Ferrari J; Grifoni F; Sciumè M; Parente R; Triggiani M; Palterer B; Mecheri V; Almerigogna F; Santi R; Di Medio L; Brandi ML; Iorno ML; Ciardetti I; Bencini S; Annunziato F; Mannarelli C; Pieri L; Guglielmelli P; Mannelli F; Vannucchi AM
J Allergy Clin Immunol; 2023 Feb; 151(2):485-493.e11. PubMed ID: 36309122
[TBL] [Abstract][Full Text] [Related]
10. Routine KIT p.D816V screening identifies clonal mast cell disease in patients with Hymenoptera allergy regularly missed using baseline tryptase levels alone.
Šelb J; Rijavec M; Eržen R; Zidarn M; Kopač P; Škerget M; Bajrović N; Luzar AD; Park YH; Liu Y; Šerbec VČ; Zver S; Košnik M; Lyons JJ; Korošec P
J Allergy Clin Immunol; 2021 Aug; 148(2):621-626.e7. PubMed ID: 33753098
[TBL] [Abstract][Full Text] [Related]
11. Genetic Regulation of Tryptase Production and Clinical Impact: Hereditary Alpha Tryptasemia, Mastocytosis and Beyond.
Sprinzl B; Greiner G; Uyanik G; Arock M; Haferlach T; Sperr WR; Valent P; Hoermann G
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671092
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of inherited genetic differences in human tryptases: Hereditary alpha-tryptasemia and beyond.
Glover SC; Carter MC; Korošec P; Bonadonna P; Schwartz LB; Milner JD; Caughey GH; Metcalfe DD; Lyons JJ
Ann Allergy Asthma Immunol; 2021 Dec; 127(6):638-647. PubMed ID: 34400315
[TBL] [Abstract][Full Text] [Related]
13. Clonal mast cell disorders and hereditary α-tryptasemia as risk factors for anaphylaxis.
Kačar M; Rijavec M; Šelb J; Korošec P
Clin Exp Allergy; 2023 Apr; 53(4):392-404. PubMed ID: 36654513
[TBL] [Abstract][Full Text] [Related]
14. Alpha-Tryptase as a Risk-Modifying Factor for Mast Cell-Mediated Reactions.
Shin H; Lyons JJ
Curr Allergy Asthma Rep; 2024 Apr; 24(4):199-209. PubMed ID: 38460022
[TBL] [Abstract][Full Text] [Related]
15. Patients with mast cell activation symptoms and elevated baseline serum tryptase level have unique bone marrow morphology.
Giannetti MP; Akin C; Hufdhi R; Hamilton MJ; Weller E; van Anrooij B; Lyons JJ; Hornick JL; Pinkus G; Castells M; Pozdnyakova O
J Allergy Clin Immunol; 2021 Apr; 147(4):1497-1501.e1. PubMed ID: 33248113
[TBL] [Abstract][Full Text] [Related]
16. Mast cell activation in the context of elevated basal serum tryptase: genetics and presentations.
Khoury P; Lyons JJ
Curr Allergy Asthma Rep; 2019 Nov; 19(12):55. PubMed ID: 31776770
[TBL] [Abstract][Full Text] [Related]
17. Resolving the genetics of human tryptases: implications for health, disease, and clinical use as a biomarker.
O'Connell MP; Lyons JJ
Curr Opin Allergy Clin Immunol; 2022 Apr; 22(2):143-152. PubMed ID: 35197435
[TBL] [Abstract][Full Text] [Related]
18. Hereditary alpha-tryptasemia in 101 patients with mast cell activation-related symptomatology including anaphylaxis.
Giannetti MP; Weller E; Bormans C; Novak P; Hamilton MJ; Castells M
Ann Allergy Asthma Immunol; 2021 Jun; 126(6):655-660. PubMed ID: 33465452
[TBL] [Abstract][Full Text] [Related]
19. Differential mast cell mediators in systemic mastocytosis and hereditary α-tryptasemia.
Giannetti MP; Godwin G; Weller E; Butterfield JH; Castells M
J Allergy Clin Immunol; 2022 Nov; 150(5):1225-1227. PubMed ID: 35550148
[TBL] [Abstract][Full Text] [Related]
20. Hereditary Alpha Tryptasemia: Validation of a Single-Well Multiplex Digital Droplet PCR Assay in a Cohort of Symptomatic Patients.
Alheraky A; Wierenga ATJ; Simpelaar A; Hesp LB; Minovic I; Bagheri N; Roozendaal C; Span LFR; Oude Elberink HNG; Kema IP; Mulder AB
Clin Chem; 2024 Feb; 70(2):425-433. PubMed ID: 38073287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
